Techs to the rescue: new study tests if radiology staff can catch cancer treatment side effects
NCT ID NCT05404308
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tests whether adding a weekly check-in with a radiology technician (called a MERM) to standard doctor visits can better detect side effects in brain tumor patients receiving proton therapy. About 92 adults with brain or upper airway tumors will be randomly assigned to either standard follow-up or the extra technician consultation. The goal is to see if this teamwork approach improves how often side effects needing treatment are caught.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could show that trained radiology technicians can help catch treatment side effects earlier, improving patient care during proton therapy.
- What could go wrong
- This is a small, early-stage study focused on monitoring, not a new treatment. It may not prove that technician-led checks are better than standard doctor visits.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 92 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
May 2023
- Expected to finish
-
Jul 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patient \> 18 years; * Patient with malignant or benign brain or upper aerodigestive tract (ADT) tumor candidate for proton therapy; * WHO score \< 2 * Mastery of the French language; * Patient affiliated with a social security system; * Signature of informed consent prior to any specific procedure related to the study. Exclusion Criteria: * Patient with another cancer previously treated with radiation therapy; * Simultaneous participation in a therapeutic clinical trial; * Patient deprived of liberty or under guardianship; * Any associated medical or psychological condition that may compromise the patient's ability to participate in the study * Patient unable to undergo trial monitoring for geographical, social or psychopathological reasons.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Brain tumor are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre François Baclesse
Caen, 14076, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Butter-Derived supplement protect the gut during cancer radiation?
- Can repeated MRI scans reveal how tumors respond to radiation?
- Can radiation before or after breast reconstruction improve outcomes?
- Brain surgery delirium: can real-time monitoring protect older patients?
- A sharper MRI could reveal radiation sensitivity of brain tumors
- Music as medicine: could ukulele lessons rebuild young brains after cancer?